drugset / Trial / NCT02476175
Add-on Mirabegron in Pediatric Patients With Refractory Overactive Bladder
NaSingle-groupOpen-labelTreatment
Summary
The objective is to evaluate the efficacy and safety of adding mirabegron to an antimuscarinic to treat urinary incontinence in children with Overactive Bladder that are refractory to antimuscarinics.
Timeline
- Start
- 2013-04
- Primary completion
- 2016-04
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirabegron | Other / unclassified | 25 mg | — |
| Subject | Mirabegron | Other / unclassified | 50 mg | — |